# DSM Venturing

> DSM Venturing is a VC fund in Heerlen backing Health Care and Biotechnology. See 94 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Heerlen, The Netherlands
- Total investments: 94
- Last investment: Jan 2026
- Lead investor: 51%
- Last fund: May 2012
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/showcase/dsm-venturing/
- Website: https://www.dsm.com/corporate/about/businesses/dsm-venturing.html

DSM Venturing is a VC fund in Heerlen focused on Health Care and Biotechnology. Founded in 2002, DSM Venturing is the corporate venture capital arm of Royal DSM, based in Heerlen, Netherlands. The firm invests in companies developing innovative products and services in sectors of life sciences (animal and human health & nutrition) and biomedical.

## Contacts

5 contacts available for DSM Venturing. Shizune tracks 9 team members at DSM Venturing. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/dsm-venturing?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $3.5M–$32M |
| Series B | $5.6M–$30M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 27 | 29% |
| Biotechnology | 26 | 28% |
| Manufacturing | 15 | 16% |
| Medical Device | 9 | 10% |
| Wellness | 8 | 9% |

70 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 30 | 32% |
| Funding Round | 18 | 19% |
| Series B | 16 | 17% |
| Seed | 8 | 9% |
| Series C | 8 | 9% |

9 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 37 | 39% |
| Canada | 5 | 5% |
| Israel | 5 | 5% |
| United Kingdom | 5 | 5% |
| The Netherlands | 5 | 5% |

10 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Akshat Kshetrapal | Investment Director | 3 | https://shizune.co/investors/profile/akshat-kshetrapal-bfc7 |
| Arpesh Mehta | Investment Director | 3 | https://shizune.co/investors/profile/arpesh-mehta |
| Greg McParland | Investment Director | 1 | https://shizune.co/investors/profile/greg-mcparland |
| Iulian Baxan | Analyst | 0 | https://shizune.co/investors/profile/iulian-baxan |
| Luda Kopeikina | Investment Director | 0 | https://shizune.co/investors/profile/luda-kopeikina |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Octarine Bio | Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry. | $5.9M | Series A | Jan 22, 2026 |  |
| Athian | Athian enables animal agriculture producers to monetize their sustainability efforts — whether it's past work or progress towards a future sustainability goal. | $4M | Series A | Nov 19, 2025 |  |
| Meala Foodtech | Meala Foodtech develops functional proteins for multiple meat replacements. Meala uses naturally occurring biocatalysts to treat plant-based proteins. |  | Seed | Jun 03, 2025 |  |
| Vivici | Vivici is a B2B ingredients firm that provides nutritious and sustainable animal-free dairy proteins manufactured with precision fermentation to food and beverage manufacturers. | $34.2M | Series A | Feb 25, 2025 |  |
| NutriLeads | NutriLeads is an innovative startup that develops nutritional ingredients with demonstrated health effects. NutriLeads aims to catalyze nutritional health innovation in the food industry by partnering with relevant companies to identify promising lead ingredients, develop sustainable and commercially viable production processes, and initiatescientific & clinical programs to substantiate the health effects of these ingredients. Together we will bring the benefits of the proprietary ingredients to patients and consumers. | $4.9M | Series C | Dec 18, 2023 |  |
| Octarine Bio | Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry. | $4.7M | Series A | Nov 08, 2023 |  |
| Vivici | Vivici is a B2B ingredients firm that provides nutritious and sustainable animal-free dairy proteins manufactured with precision fermentation to food and beverage manufacturers. |  | Seed | Aug 14, 2023 |  |
| Meatable | Meatable is a food production company that produces guilt-free meat. Meatable is a company that creates manufactured meat using stem cell technology. By employing pluripotent stem cells, which have the potential to transform any type of cell from muscle to fat without serum, the company's method eliminates the need to remove any tissue from ananimal, allowing consumers to have sustainable food. | $34M | Series B | Aug 07, 2023 |  |
| Incredo | DouxMatok is a food-tech company. They have developed a proprietary technology that enhances the sweetness of sugars with no after taste - preserving the full "sugar experience" customers are looking for. The enhanced sweetness allows for a significant reduction in the consumption of sugar.The company was incorporated in 2014, and itsR&D center is based in Petach-Tikva, Israel. | $30M | Series C | May 24, 2023 |  |
| VitaminLab | VitaminLab takes your health history, our nutrient testing or health data, and uses our matching algorithm to create an all-in-one personalized supplement that impacts your health. The company, run by a team of pharmacists and health care professionals, was founded to change the status quo of the supplement industry. |  | Series A | May 08, 2023 |  |

10 of 94 investments shown.

## Co-investors
- [Thuja Capital](https://shizune.co/investors/profile/thuja-capital) — VC Fund, 5 deals together
- [BASF Venture Capital](https://shizune.co/investors/profile/basf-venture-capital) — VC Fund, 3 deals together
- [Burrill & Company](https://shizune.co/investors/profile/burrill-co) — VC Fund, 3 deals together
- [Cibus Fund](https://shizune.co/investors/profile/cibus-fund) — VC Fund, 3 deals together
- [Clean Energy Ventures](https://shizune.co/investors/profile/clean-energy-ventures-cev) — VC Fund, 3 deals together
- [Oskare Capital](https://shizune.co/investors/profile/oskare-capital) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Oqal](https://shizune.co/investors/profile/oqal) — VC Fund
- [Wa’ed Ventures](https://shizune.co/investors/profile/waed-ventures) — VC Fund
- [Vision Ventures](https://shizune.co/investors/profile/vision-ventures-2) — VC Fund

## Featured in investor lists
- [Food and Beverage Investors](https://shizune.co/investors/food-and-beverage-investors)
- [Food and Beverage VC Funds](https://shizune.co/investors/food-and-beverage-vc-funds)
- [Wellness VC Funds](https://shizune.co/investors/wellness-vc-funds)
- [Fitness Investors](https://shizune.co/investors/fitness-investors)
- [Fitness VC Funds](https://shizune.co/investors/fitness-vc-funds)
- [Food and Beverage VC Funds in Canada](https://shizune.co/investors/food-and-beverage-vc-funds-canada)

## FAQ

### What does DSM Venturing invest in?

DSM Venturing invests primarily in Health Care, Biotechnology and Manufacturing startups, most often at Series A and Funding Round stage. Most of the 94 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is DSM Venturing's check size?

DSM Venturing typically joins rounds of $3.5M–$32M at Series A and $5.6M–$30M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds DSM Venturing participates in.

### How do I contact DSM Venturing?

Public channels for DSM Venturing include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at DSM Venturing?

The team at DSM Venturing includes Akshat Kshetrapal (Investment Director), Arpesh Mehta (Investment Director) and Greg McParland (Investment Director), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co